Bausch Health Companies (BHC) - Market Capitalization

Bausch Health Companies (BHC) is a diversified player whose success depends on Xifaxan sales, promising dermatological developments, and the resolution of patent conflicts. The linear price action on the chart, where the market capitalization stands at 3.12, demonstrates business resilience through its reach in ophthalmology and gastroenterology. To reduce its debt load, Bausch Health Companies (BHC) delegates the production of legacy product lines to contractors, freeing up funds for scientific research.

BHC bauschhealth.com: Market Valuation in the range 07/04/2022 - 11/12/2026

Metric breakdowns and analytics for Bausch Health Corp (BHC)

- current price and projected stock value:

Stock Price Bausch Health|BHC - Fair Value Consensus

- market capitalization indicators:

Market Capitalization Bausch Health Corp|BHC - Real Price to Acquire Entire Company

- issuer book value statistics:

Net Assets per Single Share Bausch Health|BHC - Net Asset Value|Market Capitalization to Book Value Ratio bauschhealth.com|BHC - Aggregate Asset Value

- debt level and financial liquidity data:

- business earnings and investment ratios data:

BHC - Final Profit|Projected Future Earnings Bausch Health Companies|BHC - Company Value to Net Income|Future Price to Earnings Valeant Pharmaceuticals|BHC - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bausch Health Corp|BHC - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Bausch Health|BHC - Earnings per share for the last 12 months|Quarterly EPS earnings growth bauschhealth.com|BHC - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Bausch Health Companies

Summary company analysis:BHC (Bausch Health)

Product sample of Bausch Health Companies

Market capitalization measures the aggregate value of all the issuer's shares, reflecting the current market valuation of the business and its investment attractiveness. Analyzing the current market capitalization of Bausch Health Companies (BHC) allows for a comparison of the company's asset value with its defensive profile in ophthalmology and pharmaceuticals, where stable demand for equipment and drugs, coupled with debt reduction, ensures sustainable growth in free cash flow.

Competitors of Bausch Health Companies (BHC)